Statistical excellence in the pharmaceutical industry
About the award
The award for statistical excellence in the pharmaceutical industry is made jointly with the RSS (Royal Statistical Society) every year.
The award is for the most influential example of the application of an existing statistical practice, or the implementation of an innovative statistical practice, in this industry.
We are looking for entries that have demonstrated one or more of the following:
- A clear understanding of the needs of researchers and investigators
- An application of an existing statistical practice to a new area that has increased the quality and efficiency of investigations
- A new development in the design of investigations and/or the analysis of data that has led to further insights into the safety, efficacy and value of medicines or devices
- An excellent way to communicate results that is clear and helpful to a wide array of users, showing how statisticians understand the range of user needs
Nominees can be based anywhere in the world and do not need to be a member of PSI or the RSS. The award is usually presented at the Annual PSI Conference.
In 2019, two joint winners were announced as follows:
Mike Smith for his work on ‘Excellence in research around population modelling in drug development’ and its ‘pioneering practical Bayesian methods with drug development in the context of optimising decision making within trials and modelling dose response with pharmacokinetic/pharmacodynamic modelling’.
Graeme Archer and Jacquie Christie were recognised for their work, ‘Quantitative Decision-Making for clinical development’, which was deemed to be ‘at the cutting edge of revolutionising data driven decision making within the industry’.
Read more about the 2019 winners.